An eruption secondary to intravenous immunoglobulin therapy.
A 42-year-old woman presented with a recurrent eruption over the distal extremities. Lesions formed a few days after initiation of intravenous immunoglobulin (IVIg) therapy and lasted 2 to 3 weeks after therapy completion. Results of a histologic examination revealed parakeratosis, exocytosis, and spongiosis. The clinical and histologic findings are similar to previous reports. The mechanism of this eruption is not known.
Mutasim
Diya F
DF
Department of Dermatology, University of Cincinnati, OH 45267-0592, USA. diya.mutasim@uc.edu
Sheth
Pranav B
PB
D000328:Adult; D003937:Diagnosis, Differential; D003875:Drug Eruptions / Q000175:diagnosis* / Q000209:etiology / Q000473:pathology; D005121:Extremities; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000009:adverse effects*; D011115:Polyneuropathies / Q000188:drug therapy*
D016756:Immunoglobulins, Intravenous